Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Echo IQ

  • Home
  •  
  • Echo IQ



  • Most Read
  • Latest Comments
  • EchoIQ develops AI to detect heart failure, lays out FDA pathway
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • EchoIQ develops AI to detect heart failure, lays out FDA pathway
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • EchoIQ develops AI to detect heart failure, lays out FDA pathway
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • EchoIQ develops AI to detect heart failure, lays out FDA pathway
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • EchoIQ develops AI to detect heart failure, lays out FDA pathway
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Spacetalk Leverages AI to Help Wearables PredictHealth Risks
    Spacetalk Leverages AI to Help Wearables PredictHealth Risks
    • News

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • City of Calgary engages SenSen for more smart city tech
    City of Calgary engages SenSen for more smart city tech
    • News

  • Interest in captioning tech sees jump in earnings for AI-Media
    Interest in captioning tech sees jump in earnings for AI-Media
    • News

  • EchoIQ develops AI to detect heart failure, lays out FDA pathway
    • News

    EchoIQ develops AI to detect heart failure, lays out FDA pathway

    In Australia, heart failure affects over half a million individuals, making up over 150,000 hospitalisations per year, over 60,000 deaths, and a cost of over $3 billion. Globally, heart failure affects more than 60 million people and is the world’s leading cause of hospitalisation in people over 65 years. It makes up 17% of all

    Read More
    Public
  • Gold Coast Private Hospital becomes first buyer for Echo IQ’s SaaS-enabled heart disease detector EchoSolv
    • News

    Gold Coast Private Hospital becomes first buyer for Echo IQ’s SaaS-enabled heart disease detector EchoSolv

    If left untreated, aortic stenosis, i.e. heart valve disease, carries a high 2-5 year mortality rate. What’s more, fewer women compared to men receive an accurate diagnosis of the disease. So, in a matter of life and death, artificial intelligence (AI) shines through, with AI and MedTech company Echo IQ (ASX: EIQ) having found a

    Read More
    Public
  • EchoIQ’s EchoSolv AI tech detects severe aortic stenosis with accuracy
    • News

    EchoIQ’s EchoSolv AI tech detects severe aortic stenosis with accuracy

    The team at Echo IQ (ASX: EIQ), who have been excelling AI medical tech, is happy to say that their tech can finally detect and diagnose the early stages of severe aortic stenosis (heart disease) following positive results from the clinical study conducted with Beth Israel Deaconess Medical Center (BIDMC), the world-renowned teaching hospital affiliated

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.